Hoang TPT, Schindler P, Börner N, Masthoff M, Gerwing M, von Beauvais P, De Toni EN, Lange CM, Trebicka J, Morgül H, Seidensticker M, Ricke J, Pascher A, Guba M, Ingrisch M, Wildgruber M, Öcal O

Journal of Hepatocellular Carcinoma 2023, 10:2277-2289

Published Date: 18 December 2023

Original Research

Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Gao B, Yang F, Zheng D, Hu S, Liu J, Liu H, Liu Y, Liu L, Wang R, Zhao Y, Cui C, Fang C, Yang J, Su S, Han Y, Yang X, Li B

Journal of Hepatocellular Carcinoma 2023, 10:2265-2276

Published Date: 13 December 2023

Original Research

Survival Prediction Model for Patients with Hepatocellular Carcinoma and Extrahepatic Metastasis Based on XGBoost Algorithm

Lim J, Jeon HG, Seo Y, Kim M, Moon JU, Cho SH

Journal of Hepatocellular Carcinoma 2023, 10:2251-2263

Published Date: 13 December 2023

Original Research

Development and Validation of a Prognostic Model for Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma Based on Preoperative Serum Prealbumin

Xu L, Zhao D, Tian P, Ding J, Jiang Z, Ni G, Hou Z, Ni C

Journal of Hepatocellular Carcinoma 2023, 10:2239-2250

Published Date: 13 December 2023

Original Research

Nomogram for Estimation of Acute Liver Failure Risk in Spontaneous Ruptured Hepatocellular Carcinoma

Zhao ZH, Jiang C, Wu QY, Lv GY, Wang M

Journal of Hepatocellular Carcinoma 2023, 10:2223-2237

Published Date: 12 December 2023

Original Research

The Safety and Efficacy of Hepatic Arterial Infusion Chemotherapy Combined with PD-(L)1 Inhibitors and Molecular Targeted Therapies for the Treatment of Intermediate and Advanced Hepatocellular Carcinoma Unsuitable for Transarterial Chemoembolization

Tang HH, Zhang MQ, Zhang ZC, Fan C, Jin Y, Wang WD

Journal of Hepatocellular Carcinoma 2023, 10:2211-2221

Published Date: 12 December 2023

Original Research

Liver Regeneration-Related Genes of Nontumor Liver Tissues Predict the Prognosis of Patients with Hepatocellular Carcinoma

Xu Y, Li Y, Lu Y, Wang W, Lian Z, Wu Z, Li B, Yu D

Journal of Hepatocellular Carcinoma 2023, 10:2197-2209

Published Date: 7 December 2023

Original Research

Implanting Iodine-125 Seed Strand Inside the Portal Vein Stent: An Improved Approach to Endovascular Brachytherapy for Treatment of Patients with Hepatocellular Carcinoma and Main Portal Vein Tumor Thrombus

Zhang L, Wang J, Li Y, Hou L, Xia J, Shen J

Journal of Hepatocellular Carcinoma 2023, 10:2187-2196

Published Date: 6 December 2023

Original Research

miR-612 Enhances RSL3-Induced Ferroptosis of Hepatocellular Carcinoma Cells via Mevalonate Pathway

Xing K, Bian X, Shi D, Dong S, Zhou H, Xiao S, Bai J, Wu W

Journal of Hepatocellular Carcinoma 2023, 10:2173-2185

Published Date: 6 December 2023

Original Research

Clinical Complete Response After Conversion Therapy for Unresectable Hepatocellular Carcinoma: Is Salvage Hepatectomy Necessary?

Wu JY, Wu JY, Liu DY, Li H, Zhuang SW, Li B, Zhou JY, Huang JY, Zhang ZB, Li SQ, Yan ML, Wang YD

Journal of Hepatocellular Carcinoma 2023, 10:2161-2171

Published Date: 5 December 2023

Corrigendum

The Feasibility of Using Tri-Exponential Intra-Voxel Incoherent Motion DWI for Identifying the Microvascular Invasion in Hepatocellular Carcinoma [Corrigendum]

Zhang Y, Sheng R, Yang C, Dai Y, Zeng M

Journal of Hepatocellular Carcinoma 2023, 10:2159-2160

Published Date: 2 December 2023

Original Research

Updates in Characteristics and Survival Rates of Hepatocellular Carcinoma in a Nationwide Cohort of Real-World US Patients, 2003–2021

Tran S, Zou B, Kam L, Lee K, Huang DQ, Henry L, Cheung R, Nguyen MH

Journal of Hepatocellular Carcinoma 2023, 10:2147-2158

Published Date: 2 December 2023

Original Research

Systemic Inflammation Score Using Pretherapeutic Inflammatory Markers to Predict Prognosis for Hepatocellular Carcinoma Patients After Hepatic Arterial Infusion Chemotherapy

Wu T, Zheng Z, Wang J, He M, Wang J, Pan Y, Chen J, Hu D, Zhang Y, Xu L, Chen M, Zhou Z

Journal of Hepatocellular Carcinoma 2023, 10:2133-2145

Published Date: 1 December 2023

Original Research

Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy

Zheng Z, Wang J, Wu T, He M, Wang J, Pan Y, Chen J, Hu D, Xu L, Zhang Y, Chen M, Zhou Z

Journal of Hepatocellular Carcinoma 2023, 10:2117-2132

Published Date: 30 November 2023

Original Research

Machine Learning-Based CEMRI Radiomics Integrating LI-RADS Features Achieves Optimal Evaluation of Hepatocellular Carcinoma Differentiation

Liu HF, Lu Y, Wang Q, Lu YJ, Xing W

Journal of Hepatocellular Carcinoma 2023, 10:2103-2115

Published Date: 29 November 2023

Corrigendum

Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma [Corrigendum]

Omar A, Kaseb A, Elbaz T, El-Kassas M, El Fouly A, Hanno AF, El Dorry A, Hosni A, Helmy A, Saad AS, Alolayan A, Eysa BE, Hamada E, Azim H, Khattab H, Elghazaly H, Tawfik H, Ayoub H, Khaled H, Saadeldin I, Waked I, Barakat EMF, El Meteini M, Hamed Shaaban M, EzzElarab M, Fathy M, Shaker M, Sobhi M, Shaker MK, ElGharib M, Abdullah M, Mokhtar M, Elshazli M, Heikal OMK, Hetta O, ElWakil RM, Abdel Wahab S, Eid SS, Rostom Y

Journal of Hepatocellular Carcinoma 2023, 10:2101-2102

Published Date: 24 November 2023

Review

Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma

Li Z, Zhang Z, Fang L, Zhao J, Niu Z, Chen H, Cao G

Journal of Hepatocellular Carcinoma 2023, 10:2083-2099

Published Date: 21 November 2023

Original Research

Prognosis Prediction of CRAFITY Score in HCC Undergoing TACE Combined with PD-(L)1 Inhibitors and Molecular Targeted Therapy

Hu ZX, Xu XY, Wang Z, Huang JT, Li WC, Zhang S, Shen J, Zhong BY, Zhu XL

Journal of Hepatocellular Carcinoma 2023, 10:2073-2082

Published Date: 21 November 2023

Original Research

Prognostic Factors for Patients with Proliferative Hepatocellular Carcinoma After Liver Resection

Li HM, Huang W, Hu C, Zhang ZS, Xiao YD, Wang TC

Journal of Hepatocellular Carcinoma 2023, 10:2059-2071

Published Date: 20 November 2023

Original Research

Pretreatment Neutrophil-to-Lymphocyte Ratio as Prognostic Biomarkers in Patients with Unresectable Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab

Xiao Y, Zhu G, Xie J, Luo L, Deng W, Lin L, Tao J, Hu Z, Shan R

Journal of Hepatocellular Carcinoma 2023, 10:2049-2058

Published Date: 9 November 2023

Original Research

Effectiveness and Safety of the PD-1 Inhibitor Lenvatinib Plus Radiotherapy in Patients with HCC with Main PVTT: Real-World Data from a Tertiary Centre

Li G, Zhao Y, Li K, Yang S, Xiang C, Song J, Yang Y, Li G, Dong J

Journal of Hepatocellular Carcinoma 2023, 10:2037-2048

Published Date: 9 November 2023

Original Research

AHSA1 Regulates Hepatocellular Carcinoma Progression via the TGF-β/Akt-Cyclin D1/CDK6 Pathway

Gao Y, Li Y, Liu Z, Dong Y, Yang S, Wu B, Xiao M, Chen C, Wen Y, Chen L, Jiang H, Yao Y

Journal of Hepatocellular Carcinoma 2023, 10:2021-2036

Published Date: 8 November 2023

Original Research

Early C‐reactive Protein Kinetics Predict Response to Immune Checkpoint Blockade in Unresectable Hepatocellular Carcinoma

Qin Q, Kou X, Zheng Y, Zhou F, Zhang X, Liu H

Journal of Hepatocellular Carcinoma 2023, 10:2009-2019

Published Date: 6 November 2023

Original Research

N6-Methyladenosine-Modified LEAWBIH Drives Hepatocellular Carcinoma Progression through Epigenetically Activating Wnt/β-Catenin Signaling

Wei H, Huang L, Lu Q, Huang Z, Huang Y, Xu Z, Li W, Pu J

Journal of Hepatocellular Carcinoma 2023, 10:1991-2007

Published Date: 6 November 2023

Original Research

Immune Effects of Cryoablation in Woodchuck Hepatocellular Carcinoma

Mauda-Havakuk M, Hawken NM, Owen JW, Mikhail AS, Starost MF, Karim B, Wakim PG, Franco-Mahecha OL, Lewis AL, Pritchard WF, Karanian JW, Wood BJ

Journal of Hepatocellular Carcinoma 2023, 10:1973-1990

Published Date: 6 November 2023

Review

Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma

Manfredi GF, Celsa C, John C, Jones C, Acuti N, Scheiner B, Fulgenzi CAM, Korolewicz J, Pinter M, Gennari A, Mauri FA, Pirisi M, Minisini R, Vincenzi F, Burlone M, Rigamonti C, Donadon M, Cabibbo G, D'Alessio A, Pinato DJ

Journal of Hepatocellular Carcinoma 2023, 10:1955-1971

Published Date: 3 November 2023

Original Research

A Single-Step Immunocapture Assay to Quantify HCC Exosomes Using the Highly Sensitive Fluorescence Nanoparticle-Tracking Analysis

Koksal AR, Ekmen N, Aydin Y, Nunez K, Sandow T, Delk M, Moehlen M, Thevenot P, Cohen A, Dash S

Journal of Hepatocellular Carcinoma 2023, 10:1935-1954

Published Date: 2 November 2023

Original Research

Treatment Outcomes in Patients with Advanced Fibrolamellar Hepatocellular Carcinoma Under Systemic Treatment: Analysis of Clinical Characteristics, Management, and Radiomics

Da Fonseca LG, Yamamoto VJ, Trinconi Cunha M, Torre GS, Araujo RL, Fonseca GM, Chen ATC, Chagas AL, Herman P, Alves VAF, Carrilho FJ

Journal of Hepatocellular Carcinoma 2023, 10:1923-1933

Published Date: 1 November 2023

Review

Evidence to Date: Clinical Utility of Tremelimumab in the Treatment of Unresectable Hepatocellular Carcinoma

Ahmed Z, Lee SS, Victor DW 3rd, Kodali S

Journal of Hepatocellular Carcinoma 2023, 10:1911-1922

Published Date: 27 October 2023

Original Research

Efficacy and Safety of Transarterial Chemoembolization with a Three-Stage Mixed Chemoembolic Regimen for Large Unresectable Hepatocellular Carcinoma

Yang Y, Du N, Ma J, Peng Z, Zhou B, Yu J, Zhou X, Zhang W, Yan Z

Journal of Hepatocellular Carcinoma 2023, 10:1897-1910

Published Date: 25 October 2023

Original Research

Development and Validation of a Prediction Model for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients Receiving Postoperative Adjuvant Transarterial Chemoembolization

Tu X, Zhang J, Li M, Lu F, Wang T, Gong W, Xiang B

Journal of Hepatocellular Carcinoma 2023, 10:1881-1895

Published Date: 24 October 2023

Case Series

The Extended Surgical Concepts for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors

Hsu HM, Tsai HI, Lee WC, Wang CC, Yu MC, Lin SM, Lin CY, Wu CH, Lee CW

Journal of Hepatocellular Carcinoma 2023, 10:1873-1880

Published Date: 24 October 2023

Original Research

Hepatocellular Carcinoma with Radiological Progression: Lenvatinib Plus PD-1 Inhibitor Combined with Microwave Ablation and Synchronous Transarterial Chemoembolization

Shi Q, Huang P, Zhang Z, Zhang W, Liu L, Yan Z

Journal of Hepatocellular Carcinoma 2023, 10:1861-1871

Published Date: 21 October 2023

Original Research

Comparable Clinical Outcomes Between Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma

Long T, Yang Z, Zeng H, Wu W, Hu Z, Yang Z, Hu D, Zhou Z, Chen M, Zhang Y

Journal of Hepatocellular Carcinoma 2023, 10:1849-1859

Published Date: 20 October 2023

Original Research

Efficacy and Safety of Microwave Ablation Assisted by Ultrasound Fusion Imaging for Primary and Secondary Liver Cancers with a Diameter of 3–7 Cm

Yang J, Liang S, Liu H, Hu C, Guan S, Kang H, Xu E, Yan R

Journal of Hepatocellular Carcinoma 2023, 10:1839-1848

Published Date: 18 October 2023

Original Research

Early Tumor Marker Response Predicts Treatment Outcomes in Patients with Unresectable Hepatocellular Carcinoma Receiving Combined Lenvatinib, Immune Checkpoint Inhibitors, and Transcatheter Arterial Chemoembolization Therapy

Luo MC, Wu JY, Wu JY, Lin ZT, Li YN, Zeng ZX, Wei SM, Yan ML

Journal of Hepatocellular Carcinoma 2023, 10:1827-1837

Published Date: 12 October 2023

Original Research

Beta2-Microglobulin as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram

Lin Q, Jiang Z, Mo D, Liu F, Qin Y, Liang Y, Cheng Y, Huang H, Fang M

Journal of Hepatocellular Carcinoma 2023, 10:1813-1825

Published Date: 11 October 2023

Original Research

Transarterial Chemoembolization Plus Lenvatinib and PD-1 Inhibitors for Hepatocellular Carcinoma with Main Trunk Portal Vein Tumor Thrombus: A Multicenter Retrospective Study

Li SQ, Wu JY, Wu JY, Xie H, Li JH, Zeng ZX, Fu YK, Liu DY, Li H, Chen WZ, Huang JY, Yan ML

Journal of Hepatocellular Carcinoma 2023, 10:1799-1811

Published Date: 11 October 2023

Original Research

Associations Between Single Nucleotide Polymorphisms of Hypoxia-Related Genes and Capsule Formation in Hepatocellular Carcinoma

Chen S, Duan Y, Zhang Y, Cheng L, Cai L, Hou X, Li W

Journal of Hepatocellular Carcinoma 2023, 10:1785-1797

Published Date: 10 October 2023

Original Research

Expression of CKS2 in Hepatocellular Carcinoma: Correlation with Survival Outcomes and Immune Microenvironment

Zhi R, Hao P, Li W, Zhao H

Journal of Hepatocellular Carcinoma 2023, 10:1767-1784

Published Date: 9 October 2023

Original Research

Identification of a Novel Prognostic Signature Based on N-Linked Glycosylation and Its Correlation with Immunotherapy Response in Hepatocellular Carcinoma

Lin SS, Cao Y, Zhu K, Yang CN, Zhu XP, Zhang HH, Zhang R

Journal of Hepatocellular Carcinoma 2023, 10:1749-1765

Published Date: 9 October 2023

Original Research

Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibodies with Hepatic Arterial Infusion Chemotherapy or Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma

Yu B, Zhang N, Feng Y, Zhang Y, Zhang T, Wang L

Journal of Hepatocellular Carcinoma 2023, 10:1735-1748

Published Date: 6 October 2023

Review

Transarterial Chemoembolization Plus Sorafenib versus Transarterial Chemoembolization Alone for Advanced Hepatocellular Carcinoma: An Umbrella Review of Meta-Analyses and Systematic Reviews

Yan J, Wen Y, Deng M, Ye B, Liu X, Zhang L

Journal of Hepatocellular Carcinoma 2023, 10:1723-1733

Published Date: 5 October 2023

Original Research

Hepatectomy After Conversion Therapy with Hepatic Arterial Infusion Chemotherapy, Tyrosine Kinase Inhibitors and Anti-PD-1 Antibodies for Initially Unresectable Hepatocellular Carcinoma

Yu B, Zhang N, Feng Y, Zhang Y, Zhang T, Wang L

Journal of Hepatocellular Carcinoma 2023, 10:1709-1721

Published Date: 4 October 2023

Review

Safety and Efficacy of Atezolizumab and Bevacizumab Combination as a First Line Treatment of Advanced Hepatocellular Carcinoma

Zanuso V, Pirozzi A, Balsano R, Pressiani T, Rimassa L

Journal of Hepatocellular Carcinoma 2023, 10:1689-1708

Published Date: 2 October 2023

Original Research

Development and Validation of a Propionate Metabolism-Related Gene Signature for Prognostic Prediction of Hepatocellular Carcinoma

Xiao J, Wang J, Zhou C, Luo J

Journal of Hepatocellular Carcinoma 2023, 10:1673-1687

Published Date: 2 October 2023

Original Research

The Feasibility of Using Tri-Exponential Intra-Voxel Incoherent Motion DWI for Identifying the Microvascular Invasion in Hepatocellular Carcinoma

Zhang Y, Sheng R, Yang C, Dai Y, Zeng M

Journal of Hepatocellular Carcinoma 2023, 10:1659-1671

Published Date: 29 September 2023

Original Research

A Novel Gene Pair CSTF2/DPE2A Impacts Prognosis and Cell Cycle of Hepatocellular Carcinoma

Huang Y, Xu J, Xie C, Liao Y, Lin R, Zeng Y, Yu F

Journal of Hepatocellular Carcinoma 2023, 10:1639-1657

Published Date: 28 September 2023

Original Research

Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7

Jiang JQ, Huang JT, Zhong BY, Wang WD, Sun JH, Wang Q, Ding WB, Ni CF, Zhu XL

Journal of Hepatocellular Carcinoma 2023, 10:1629-1638

Published Date: 26 September 2023

Original Research

Development and Validation of a Novel Prognosis Model Based on a Panel of Three Immunogenic Cell Death-Related Genes for Non-Cirrhotic Hepatocellular Carcinoma

Gong J, Yu R, Hu X, Luo H, Gao Q, Li Y, Tan G, Luo H, Qin B

Journal of Hepatocellular Carcinoma 2023, 10:1609-1628

Published Date: 25 September 2023

Original Research

MRI Features for Predicting Microvascular Invasion and Postoperative Recurrence in Hepatocellular Carcinoma Without Peritumoral Hypointensity

Chen Z, Li X, Zhang Y, Yang Y, Zhang Y, Zhou D, Yang Y, Zhang S, Liu Y

Journal of Hepatocellular Carcinoma 2023, 10:1595-1608

Published Date: 25 September 2023

Case Series

Modified Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab for Advanced HCC: Two Case Reports

Tian Y, Jin W, Sun H, Jin D, Kang D, Li Z, Piao L

Journal of Hepatocellular Carcinoma 2023, 10:1587-1593

Published Date: 25 September 2023

Original Research

Improved Survival in At-Risk Patients Undergoing Surveillance for Hepatocellular Carcinoma – A Nationwide Swedish Register-Based Study

Thörn R, Hemmingsson O, Danielsson Borssén Å, Werner M, Karling P, Wixner J

Journal of Hepatocellular Carcinoma 2023, 10:1573-1586

Published Date: 19 September 2023

Review

Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma 2023, 10:1547-1571

Published Date: 18 September 2023

Expert Opinion

Al-Hijamah (Prophetic Wet Cupping Therapy) is a Novel Adjuvant Treatment for Viral Hepatitis That Excretes Viral Particles and Excess Ferritin Percutaneously, Synergizes Pharmacotherapy, Enhances Antiviral Immunity and Helps Better HCC Prevention and Treatment: A Novel Evidence-Based Combination with Prophetic Medicine Remedies

El Sayed SM

Journal of Hepatocellular Carcinoma 2023, 10:1527-1546

Published Date: 13 September 2023

Original Research

Efficacy of TACE Combined with Lenvatinib Plus Sintilimab for Hepatocellular Carcinoma with Tumor Thrombus in the Inferior Vena Cava and/or Right Atrium

Ning S, Li X, Ma X, Liu J, Chang X

Journal of Hepatocellular Carcinoma 2023, 10:1511-1525

Published Date: 13 September 2023

Original Research

Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib Plus Humanized Programmed Death Receptor-1 in Patients with High-Risk Advanced Hepatocellular Carcinoma: A Real-World Study

Chang X, Wu H, Ning S, Li X, Xie Y, Shao W, Yu J

Journal of Hepatocellular Carcinoma 2023, 10:1497-1509

Published Date: 6 September 2023

Original Research

N6-Methyladenosine-Modified ATP8B1-AS1 Exerts Oncogenic Roles in Hepatocellular Carcinoma via Epigenetically Activating MYC

Tan C, Huang Y, Huang Z, Ning Y, Huang L, Wu X, Lu Y, Wei H, Pu J

Journal of Hepatocellular Carcinoma 2023, 10:1479-1495

Published Date: 6 September 2023

Original Research

Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis

Ouyang J, Wang Z, Yuan K, Yang Y, Zhou Y, Li Q, Yang N, Zhao H, Zhao H, Zhou J

Journal of Hepatocellular Carcinoma 2023, 10:1465-1477

Published Date: 6 September 2023

Review

Immune-Based Combination Therapies for Advanced Hepatocellular Carcinoma

Carloni R, Sabbioni S, Rizzo A, Ricci AD, Palloni A, Petrarota C, Cusmai A, Tavolari S, Gadaleta-Caldarola G, Brandi G

Journal of Hepatocellular Carcinoma 2023, 10:1445-1463

Published Date: 6 September 2023

Original Research

Efficacy and Safety of TACE Combined with Lenvatinib and PD-(L)1 Inhibitor in the Treatment of Unresectable Hepatocellular Carcinoma: A Retrospective Study

Yang H, Yang T, Qiu G, Liu J

Journal of Hepatocellular Carcinoma 2023, 10:1435-1443

Published Date: 5 September 2023

Original Research

Naples Prognostic Score is an Independent Prognostic Factor in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma

Xie YM, Lu W, Cheng J, Dai M, Liu SY, Wang DD, Fu TW, Ye TW, Liu JW, Zhang CW, Huang DS, Liang L

Journal of Hepatocellular Carcinoma 2023, 10:1423-1433

Published Date: 4 September 2023

Review

Current Opinions on the Relationship Between CMTM Family and Hepatocellular Carcinoma

Pei Y, Zhang Z, Tan S

Journal of Hepatocellular Carcinoma 2023, 10:1411-1422

Published Date: 25 August 2023

Original Research

A Novel Nomogram for the Preoperative Prediction of Edmondson-Steiner Grade III-IV in Hepatocellular Carcinoma Patients

Zhou Z, Cao S, Chen C, Chen J, Xu X, Liu Y, Liu Q, Wang K, Han B, Yin Y

Journal of Hepatocellular Carcinoma 2023, 10:1399-1409

Published Date: 23 August 2023

Review

Establishment and Clinical Application of the Nomogram Related to Risk or Prognosis of Hepatocellular Carcinoma: A Review

Wang X, Zhao M, Zhang C, Chen H, Liu X, An Y, Zhang L, Guo X

Journal of Hepatocellular Carcinoma 2023, 10:1389-1398

Published Date: 22 August 2023

Clinical Trial Report

Efficacy of Invariant Natural Killer T Cell Infusion Plus Transarterial Embolization vs Transarterial Embolization Alone for Hepatocellular Carcinoma Patients: A Phase 2 Randomized Clinical Trial

Guo J, Bao X, Liu F, Guo J, Wu Y, Xiong F, Lu J

Journal of Hepatocellular Carcinoma 2023, 10:1379-1388

Published Date: 21 August 2023

Original Research

Sarcopenia Imperils Postoperative Long-Term Survival in HCC Patients with Metabolic Dysfunction-Associated Fatty Liver Disease: A Propensity Score Matching Analysis

Kong Q, Yi M, Teng F, Li H, Chen Z

Journal of Hepatocellular Carcinoma 2023, 10:1367-1377

Published Date: 16 August 2023

Original Research

Resection Margin Width Does Not Influence the Prognosis of Solitary Hepatocellular Carcinoma After Anatomic Resection: A Real-World Study from China

Ke Q, Guo Z, He J, Lai Z, Xin F, Zeng Y, Wang L, Liu J

Journal of Hepatocellular Carcinoma 2023, 10:1353-1365

Published Date: 16 August 2023

Original Research

Prognosis of Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization(MC-hccAI 001): Development and Validation of the ALFP Score

Gong B, Wang X, Guo W, Yang H, Shi Y, Chen Y, Gao S, Chen J, Liu L, Lu L, Chen X

Journal of Hepatocellular Carcinoma 2023, 10:1341-1351

Published Date: 11 August 2023

Original Research

Downregulated Acetyl-CoA Acyltransferase 2 Promoted the Progression of Hepatocellular Carcinoma and Participated in the Formation of Immunosuppressive Microenvironment

Wu D, Liao G, Yao Y, Huang L, Dong B, Ma Y, Yang G

Journal of Hepatocellular Carcinoma 2023, 10:1327-1339

Published Date: 9 August 2023

Original Research

Pan-Cancer Profiling and Digital Pathology Analysis Reveal Negative Prognostic Biomarker ZPR1 Associated with Immune Infiltration and Treatment Response in Hepatocellular Carcinoma

He L, Xie Y, Qiu Y, Zhang Y

Journal of Hepatocellular Carcinoma 2023, 10:1309-1325

Published Date: 9 August 2023

Original Research

Integration of Multimodal Computed Tomography Radiomic Features of Primary Tumors and the Spleen to Predict Early Recurrence in Patients with Postoperative Adjuvant Transarterial Chemoembolization

Chen C, Liu J, Gu Z, Sun Y, Lu W, Liu X, Chen K, Ma T, Zhao S, Zhao H

Journal of Hepatocellular Carcinoma 2023, 10:1295-1308

Published Date: 8 August 2023

Original Research

TRIM55 Promotes Proliferation of Hepatocellular Carcinoma Through Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling

Lu X, Yuan Y, Cai N, Rao D, Chen M, Chen X, Zhang B, Liang H, Zhang L

Journal of Hepatocellular Carcinoma 2023, 10:1281-1293

Published Date: 3 August 2023

Original Research

T-Lymphocyte Gene-Regulated CCL5 and Its Association with Extrahepatic Metastasis in Hepatocellular Carcinoma

Dong G, Fan F, He Y, Luo Y, Yu J, Liang P

Journal of Hepatocellular Carcinoma 2023, 10:1267-1279

Published Date: 2 August 2023

Original Research

PD-1 Inhibitors Combined with Antiangiogenic Therapy with or Without Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Propensity Matching Analysis

Li H, Su K, Guo L, Jiang Y, Xu K, Gu T, Chen J, Wu Z, Wang P, Zhang X, Yan Y, Li S, Wu X, Han L, He K, Wen L, Li B, Han Y

Journal of Hepatocellular Carcinoma 2023, 10:1257-1266

Published Date: 29 July 2023

Original Research

A Positive Feedback Loop of lncRNA HOXD-AS2 and SMYD3 Facilitates Hepatocellular Carcinoma Progression via the MEK/ERK Pathway

Sun J, Li Y, Shi M, Tian H, Li J, Zhu K, Guo Y, Mu Y, Geng J, Li Z

Journal of Hepatocellular Carcinoma 2023, 10:1237-1256

Published Date: 27 July 2023

Original Research

Hispanic Individuals are Underrepresented in Phase III Clinical Trials for Advanced Liver Cancer in the United States

Monge C, Maldonado JA, McGlynn KA, Greten TF

Journal of Hepatocellular Carcinoma 2023, 10:1223-1235

Published Date: 27 July 2023

Original Research

Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab with or Without Transhepatic Arterial Embolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and High Tumor Burden: A Multicenter Retrospective Study

Chen S, Shi F, Wu Z, Wang L, Cai H, Ma P, Zhou Y, Mai Q, Wang F, Tang S, Zhuang W, Lai J, Chen X, Chen H, Guo W

Journal of Hepatocellular Carcinoma 2023, 10:1209-1222

Published Date: 27 July 2023

Corrigendum

Boron Neutron Capture Therapy Eliminates Radioresistant Liver Cancer Cells by Targeting DNA Damage and Repair Responses [Corrigendum]

Huang CY, Lai ZY, Hsu TJ, Chou FI, Liu HM, Chuang YJ

Journal of Hepatocellular Carcinoma 2023, 10:1207-1208

Published Date: 26 July 2023

Original Research

Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab or Lenvatinib for Unresectable Hepatocellular Carcinoma: A Propensity Score Matched Study

Zhao C, Xiang Z, Li M, Wang H, Liu H, Yan H, Huang M

Journal of Hepatocellular Carcinoma 2023, 10:1195-1206

Published Date: 25 July 2023

Original Research

Development and Validation of Novel Models Including Tumor Micronecrosis for Predicting the Postoperative Survival of Patients with Hepatocellular Carcinoma

Sun X, Wang Y, Ge H, Chen C, Han X, Sun K, Wang M, Wei X, Ye M, Zhang Q, Liang T

Journal of Hepatocellular Carcinoma 2023, 10:1181-1194

Published Date: 25 July 2023

Original Research

The Role of miR-1183: A Potential Suppressor in Hepatocellular Carcinoma via Regulating Splicing Factor SRSF1

Yao Z, Liu N, Lin H, Zhou Y

Journal of Hepatocellular Carcinoma 2023, 10:1169-1180

Published Date: 21 July 2023

Original Research

Laparoscopic Hepatectomy versus Open Hepatectomy After Conversion Therapy Using Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy for Patients with Initially Unresectable Hepatocellular Carcinoma

Yang Z, Hu Z, Fu Y, Hu D, Zhou Z, Chen M, Pan Y, Zhang Y

Journal of Hepatocellular Carcinoma 2023, 10:1157-1167

Published Date: 21 July 2023

Original Research

Estimating Microvascular Invasion in Patients with Resectable Multinodular Hepatocellular Carcinoma by Using Preoperative Contrast-Enhanced MRI: Establishment and Validation of a Risk Score

Wu F, Sun H, Shi Z, Zhou C, Huang P, Xiao Y, Yang C, Zeng M

Journal of Hepatocellular Carcinoma 2023, 10:1143-1156

Published Date: 20 July 2023

Original Research

Effects of Clinical and Tumor Characteristics on Survival in Patients with Hepatocellular Carcinoma with Bone Metastasis

Ozer M, Goksu SY, Lin RY, Ayasun R, Kahramangil D, Rogers SC, Fabregas JC, Ramnaraign BH, George TJ, Feely M, Cabrera R, Duarte S, Zarrinpar A, Sahin I

Journal of Hepatocellular Carcinoma 2023, 10:1129-1141

Published Date: 19 July 2023

Review

Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights

Yu J, Park R, Kim R

Journal of Hepatocellular Carcinoma 2023, 10:1105-1127

Published Date: 18 July 2023

Original Research

The Long Non-Coding RNA AC006329.1 Facilitates Hepatocellular Carcinoma Progression and Metastasis by Regulating miR-127-5p/SHC3/ERK Axis

Kong XX, Yang X, Jiang WJ, Zhu DM, Kong LB

Journal of Hepatocellular Carcinoma 2023, 10:1085-1103

Published Date: 17 July 2023

Review

Application and Resistance Mechanisms of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma

Tao M, Han J, Shi J, Liao H, Wen K, Wang W, Mui S, Li H, Yan Y, Xiao Z

Journal of Hepatocellular Carcinoma 2023, 10:1069-1083

Published Date: 10 July 2023

Original Research

Infiltration of a Unique CD8+CD274+ Cell Subgroup in Hepatocellular Carcinoma is Associated with Poor Clinical Outcomes

Zhang Y, Cui K, Yang Y, Liu B, Zhu M, Chen H, Zhao C, Zhou Y, Nie Y

Journal of Hepatocellular Carcinoma 2023, 10:1051-1067

Published Date: 8 July 2023

Original Research

The Predictive Role of Inflammatory Biomarkers for Treatment Response and Progression-Free Survival in Patients with Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy with FOLFOX Regimen: A Preliminary Study

Zhao Y, Liu J, Xiong Z, Gu S, Xia X

Journal of Hepatocellular Carcinoma 2023, 10:1037-1049

Published Date: 8 July 2023

Original Research

LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma

Wei Q, Liu G, Huang Z, Huang Y, Huang L, Huang Z, Wu X, Wei H, Pu J

Journal of Hepatocellular Carcinoma 2023, 10:1019-1035

Published Date: 5 July 2023

Original Research

Construction and Validation of TACE Therapeutic Efficacy by ALR Score and Nomogram: A Large, Multicenter Study

Li H, Guo L, Su K, Li C, Jiang Y, Wang P, Chen J, Wu Z, Xu K, Gu T, Zeng H, He K, Chi H, Zhao W, Han L, Han Y

Journal of Hepatocellular Carcinoma 2023, 10:1009-1017

Published Date: 29 June 2023

Original Research

Effect of Different Liver Resection Modalities on the Prognosis of Patients with Hepatocellular Carcinoma on the Left Lateral Lobe

Liu J, Sun M, Fang K, Wang J, Ma B, Song L, Liu T, Tang M, Wang K, Xia Y

Journal of Hepatocellular Carcinoma 2023, 10:997-1007

Published Date: 28 June 2023

Original Research

Outcomes of Radiation Segmentectomy for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease versus Chronic Viral Hepatitis

De la Garza-Ramos C, Montazeri SA, Musto KR, Kapp MD, Lewis AR, Frey G, Paz-Fumagalli R, Ilyas S, Harnois DM, Majeed U, Patel T, Toskich B

Journal of Hepatocellular Carcinoma 2023, 10:987-996

Published Date: 23 June 2023

Short Report

Comparison of Ablation Volume Between Emprint® and Mimapro® Systems for Hepatocellular Carcinoma –A Preliminary Study

Ishikawa T, Hasegawa I, Hirosawa H, Honmou T, Sakai N, Igarashi T, Yamazaki S, Kobayashi T, Sato T, Iwanaga A, Sano T, Yokoyama J, Honma T

Journal of Hepatocellular Carcinoma 2023, 10:979-985

Published Date: 22 June 2023

Original Research

An Analysis Regarding the Association Between the Nuclear Pore Complex (NPC) and Hepatocellular Carcinoma (HCC)

Huang P, Hu YD, Liu YJ, Li JP, Zhang YH

Journal of Hepatocellular Carcinoma 2023, 10:959-978

Published Date: 22 June 2023

Original Research

Simultaneous and Sequential Use of Molecular Targeted Agents Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Real-World Practice in China

Li J, Huang L, Ge C, Zhu X, Qiu M, Chen C, Wei S, Yan Y

Journal of Hepatocellular Carcinoma 2023, 10:949-958

Published Date: 20 June 2023

Original Research

Phellodendronoside A Exerts Anticancer Effects Depending on Inducing Apoptosis Through ROS/Nrf2/Notch Pathway and Modulating Metabolite Profiles in Hepatocellular Carcinoma

Si Y, Hui C, Guo T, Liu M, Chen X, Dong C, Feng S

Journal of Hepatocellular Carcinoma 2023, 10:935-948

Published Date: 20 June 2023

Original Research

PD-L1 is Fascinating but IDO Needs Attention in Non-HCV and Non-HBV-Associated Hepatocellular Carcinoma Patients

Asghar K, Bashir S, Ali Rana I, Abu Bakar M, Farooq A, Hassan M, Asif Z, Afzal M, Masood I, Ishaq M, Tahseen M, Bilal S, Mehmood S, Kanwal N, Ud Din I, Loya A

Journal of Hepatocellular Carcinoma 2023, 10:921-934

Published Date: 17 June 2023

Original Research

Novel Prognostic Nomogram to Predict Progression-Free Survival of Patients with Hepatocellular Carcinoma After Transarterial Chemoembolization

Xi D, Xu M, Han M, Guan Q, Guo Q, Yan F, Yao J, Ning Q

Journal of Hepatocellular Carcinoma 2023, 10:909-920

Published Date: 16 June 2023

Review

Role of the HIF-1α/BNIP3 Signaling Pathway in Recurrent Hepatocellular Carcinoma and the Mechanism of Traditional Chinese Medicine

Liu S, Kang L, Song Y, Miao M

Journal of Hepatocellular Carcinoma 2023, 10:893-908

Published Date: 8 June 2023

Original Research

Safety and Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma: A Single Center Experience

Pan X, Wu SJ, Tang Y, Zhou YF, Luo JW, Fang ZT

Journal of Hepatocellular Carcinoma 2023, 10:883-892

Published Date: 9 June 2023

Original Research

LINC00886 Facilitates Hepatocellular Carcinoma Tumorigenesis by Sequestering microRNA-409-3p and microRNA-214-5p

Li L, Ai R, Yuan X, Dong S, Zhao D, Sun X, Miao T, Guan W, Guo P, Yu S, Nan Y

Journal of Hepatocellular Carcinoma 2023, 10:863-881

Published Date: 8 June 2023

Original Research

Population Sensitive to Lenvatinib Plus Anti-PD-1 for Unresectable Hepatocellular Carcinoma Infected with Hepatitis B Virus

Chang X, Yu S, Pang J, Zhang W, Kong H, Huang J, Zhang G, Zhang H, Gu Y, Chen Y, Yang B, Liu J, Zeng Z

Journal of Hepatocellular Carcinoma 2023, 10:847-861

Published Date: 6 June 2023

Original Research

Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors

Sun L, Zhao H, Ding XY, Yang K, Wang GS, Chen JM, Han XY, Wan G, Zhang L, Zhou XG, Chen XM, Wang P, Xie W

Journal of Hepatocellular Carcinoma 2023, 10:833-846

Published Date: 5 June 2023

Original Research

Prognostic Significance of Hemoglobin, Albumin, Lymphocyte and Platelet (HALP) Score in Hepatocellular Carcinoma

Zhou J, Yang D

Journal of Hepatocellular Carcinoma 2023, 10:821-831

Published Date: 2 June 2023

Original Research

Safety and Efficacy of Drug-Eluting Bead Transarterial Chemoembolization Combined with Lenvatinib and Anti-PD-1 Antibodies for Unresectable Hepatocellular Carcinoma: A Retrospective Analysis

Wu SJ, Ruan DD, Wu QY, Tang Y, Zhang JH, Cai SL, Zhou YF, Luo JW, Fang ZT

Journal of Hepatocellular Carcinoma 2023, 10:807-820

Published Date: 2 June 2023

Original Research

Radiomics Based on Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Preoperative Differentiation of Combined Hepatocellular-Cholangiocarcinoma from Hepatocellular Carcinoma: A Multi-Center Study

Guo L, Li X, Zhang C, Xu Y, Han L, Zhang L

Journal of Hepatocellular Carcinoma 2023, 10:795-806

Published Date: 2 June 2023

Original Research

Detection of sFas, sCD137, and IL-27 Cytokines as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis

Do XH, Le MT, Nguyen TH, Le TT, Nguyen XH, Mai TB, Hoang TMN, Than UTT

Journal of Hepatocellular Carcinoma 2023, 10:783-793

Published Date: 26 May 2023

Original Research

Screening and Verification of Key Ubiquitination Genes Related to Immune Infiltration in Stage III/IV Hepatocellular Carcinoma

Tang Y, Cao J, Peng R, Mao X, Su B, Tang H, Tu D, Zhou J, Jiang G, Jin S, Wang Q, Zhang C, Liu R, Zhang C, Bai D

Journal of Hepatocellular Carcinoma 2023, 10:765-781

Published Date: 22 May 2023

Original Research

Clinical Benefits of Neoadjuvant Radiotherapy on the Postoperative Recurrence of Centrally Located Hepatocellular Carcinoma: A Real-World Evidence Based on Phase II Clinical Trial

Tao C, Wu F, Wang H, Wang L, Liu Y, Wu A, Zheng L, Wang Y, Chen B, Rong W, Wu J

Journal of Hepatocellular Carcinoma 2023, 10:753-764

Published Date: 16 May 2023

Review

Current Advances in the Treatment of Fibrolamellar Carcinoma of Liver

Gummadi J, Wang X, Xie C

Journal of Hepatocellular Carcinoma 2023, 10:745-752

Published Date: 15 May 2023

Review

Clinical Results, Risk Factors, and Future Directions of Ultrasound-Guided Percutaneous Microwave Ablation for Hepatocellular Carcinoma

Dong TT, Wang L, Li M, Yin C, Li YY, Nie F

Journal of Hepatocellular Carcinoma 2023, 10:733-743

Published Date: 15 May 2023

Original Research

Outcomes of National Survey of the Practice of Hepatocellular Carcinoma Surveillance

Scott RA, Cross TJS, Clarke C, Khan SA, Ryder SD, Franklin J, Aravinthan AD

Journal of Hepatocellular Carcinoma 2023, 10:725-731

Published Date: 29 April 2023

Review

Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection

Costante F, Stella L, Santopaolo F, Gasbarrini A, Pompili M, Asselah T, Ponziani FR

Journal of Hepatocellular Carcinoma 2023, 10:713-724

Published Date: 25 April 2023

Original Research

Lenvatinib Induces Immunogenic Cell Death and Triggers Toll-Like Receptor-3/4 Ligands in Hepatocellular Carcinoma

Zhou C, Yang ZF, Sun BY, Yi Y, Wang Z, Zhou J, Fan J, Gan W, Ren N, Qiu SJ

Journal of Hepatocellular Carcinoma 2023, 10:697-712

Published Date: 24 April 2023

Original Research

Modified Patent Hemostasis Strategy Based on the Platelet Counts for Transradial Access Chemoembolization in Patients with Hepatocellular Carcinoma: A Prospective Single-Center Study

Luo YG, Zhang XW, Tsauo JW, Li Y, Li JG, Peng Q, Li YW, Sun W, Zhao H, Li X

Journal of Hepatocellular Carcinoma 2023, 10:687-695

Published Date: 21 April 2023

Original Research

A Retrospective Analysis of Conversion Therapy with Lenvatinib, Sintilimab, and Arterially-Directed Therapy in Patients with Initially Unresectable Hepatocellular Carcinoma

Gan L, Lang M, Tian X, Ren S, Li G, Liu Y, Han R, Zhu K, Li H, Wu Q, Cui Y, Zhang W, Fang F, Li Q, Song T

Journal of Hepatocellular Carcinoma 2023, 10:673-686

Published Date: 22 April 2023

Original Research

A Novel Neutrophil-to-Lymphocyte Ratio and Sarcopenia Based TACE-Predict Model of Hepatocellular Carcinoma Patients

Wang S, Zhang X, Chen Q, Jin ZC, Lu J, Guo J

Journal of Hepatocellular Carcinoma 2023, 10:659-671

Published Date: 20 April 2023

Original Research

Six-Transmembrane Epithelial Antigen of Prostate 4: An Indicator of Prognosis and Tumor Immunity in Hepatocellular Carcinoma

Ju MH, Jang EJ, Kang SH, Roh YH, Jeong JS, Han SH

Journal of Hepatocellular Carcinoma 2023, 10:643-658

Published Date: 20 April 2023

Original Research

Radiofrequency Ablation of Hepatocellular Carcinomas Adjacent to the Gallbladder Without Isolation Under Contrast-Enhanced Ultrasound Monitoring: A Comparative Study with Long Term Follow-Up

Luo L, Yan R, Zeng Q, Long Y, He X, Li K, Xu E

Journal of Hepatocellular Carcinoma 2023, 10:631-642

Published Date: 13 April 2023

Original Research

Inhibitory Effects of Esculetin on Liver Cancer Through Triggering NCOA4 Pathway-Mediation Ferritinophagy in vivo and in vitro

Xiu Z, Li Y, Fang J, Han J, Li S, Li Y, Yang X, Song G, Li Y, Jin N, Zhu Y, Zhu G, Sun L, Li X

Journal of Hepatocellular Carcinoma 2023, 10:611-629

Published Date: 11 April 2023

Original Research

Pre-S1 Mutations as Indicated by Serum Pre-S1 Antigen Negative is Associated with an Increased Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients

Zhang X, Gu C, Wei Q, Cao Y, She W, Shi H, Xie Y, Guo J

Journal of Hepatocellular Carcinoma 2023, 10:599-609

Published Date: 11 April 2023

Original Research

Metabolic Tumor Volume Measured by 18F-FDG PET/CT is Associated with the Survival of Unresectable Hepatocellular Carcinoma Treated with PD-1/PD-L1 Inhibitors Plus Molecular Targeted Agents

Wang X, Yang X, Wang J, Dong C, Ding J, Wu M, Wang Y, Ding H, Zhang H, Sang X, Zhao H, Huo L

Journal of Hepatocellular Carcinoma 2023, 10:587-598

Published Date: 8 April 2023

Original Research

Prognostic Analysis of Single Large Hepatocellular Carcinoma Following Radical Resection: A Single-Center Study

Huang J, Li L, Liu FC, Tan BB, Yang Y, Jiang BG, Pan ZY

Journal of Hepatocellular Carcinoma 2023, 10:573-586

Published Date: 6 April 2023

Original Research

Inhibition of Annexin A10 Contributes to ZNF281 Mediated Aggressiveness of Hepatocellular Carcinoma

Zhang X, Zhang C, Zhao Q, Wang S, Wang L, Si Y, Su Q, Cheng S, Ding W

Journal of Hepatocellular Carcinoma 2023, 10:553-571

Published Date: 5 April 2023

Original Research

Identification and Experimental Validation of the Prognostic Significance and Immunological Correlation of Glycosylation-Related Signature and ST6GALNAC4 in Hepatocellular Carcinoma

Dai T, Li J, Liang RB, Yu H, Lu X, Wang G

Journal of Hepatocellular Carcinoma 2023, 10:531-551

Published Date: 3 April 2023

Original Research

High Expression of Heterogeneous Nuclear Ribonucleoprotein A1 Facilitates Hepatocellular Carcinoma Growth

Cao Z, Guan L, Yu R, Yang F, Chen J

Journal of Hepatocellular Carcinoma 2023, 10:517-530

Published Date: 1 April 2023

Original Research

An Analysis Regarding the Association Between Proteasome (PSM) and Hepatocellular Carcinoma (HCC)

Huang W, Mei J, Liu YJ, Li JP, Zou X, Qian XP, Zhang Y

Journal of Hepatocellular Carcinoma 2023, 10:497-515

Published Date: 30 March 2023

Original Research

Synergistic Effect of Lenvatinib and Chemotherapy in Hepatocellular Carcinoma Using Preclinical Models

Wang M, Yao X, Bo Z, Zheng J, Yu H, Xie X, Lin Z, Wang Y, Chen G, Wu L

Journal of Hepatocellular Carcinoma 2023, 10:483-495

Published Date: 27 March 2023

Original Research

Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients

Benevento F, Pecorelli A, Stefanescu H, Sparchez Z, Vukotic R, Pettinari I, Grigoras CA, Tovoli F, Ravaioli F, Stefanini B, Andreone P, Piscaglia F

Journal of Hepatocellular Carcinoma 2023, 10:473-482

Published Date: 27 March 2023

Original Research

Prognostic Lysosome-Related Biomarkers for Predicting Drug Candidates in Hepatocellular Carcinoma: An Insilco Analysis

Xu J, Zhang K, Zhang G

Journal of Hepatocellular Carcinoma 2023, 10:459-472

Published Date: 21 March 2023

Original Research

The Feasibility of TACE Combined with TKIs Plus PD-1 Antibody for Advanced HCC

Sun T, Ren Y, Sun B, Chen L, Zhu L, Zhang L, Zheng C

Journal of Hepatocellular Carcinoma 2023, 10:447-457

Published Date: 16 March 2023

Original Research

LncRNA TGFB2-OT1 Promotes Progression and Angiogenesis in Hepatocellular Carcinoma by Dephosphorylating β-Catenin

Chen Y, Wu X, Chen X, Guo D, Ma W, Guo Y, Xu K, Ma S, Yuan Y, Zhu Q

Journal of Hepatocellular Carcinoma 2023, 10:429-446

Published Date: 14 March 2023

Review

Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes

Ito T, Nguyen MH

Journal of Hepatocellular Carcinoma 2023, 10:413-428

Published Date: 10 March 2023

Original Research

Prognosis of Primary Liver Cancer Based on LI-RADS Classification with Extracellular Agent-Enhanced MRI

Li Y, Ni X, Liu X, Yang C, Wang Y, Lu X, Zhou C

Journal of Hepatocellular Carcinoma 2023, 10:399-411

Published Date: 9 March 2023

Original Research

Vessels That Encapsulate Tumor Clusters (VETC) Predict cTACE Response in Hepatocellular Carcinoma

Lin C, He Y, Liu M, Wu A, Zhang J, Li S, Li S, Cao Q, Liu F

Journal of Hepatocellular Carcinoma 2023, 10:383-397

Published Date: 7 March 2023

Original Research

Comprehensive Genomic Profiling Identifies FAT1 as a Negative Regulator of EMT, CTCs, and Metastasis of Hepatocellular Carcinoma

Huang ZL, Zhang PB, Zhang JT, Li F, Li TT, Huang XY

Journal of Hepatocellular Carcinoma 2023, 10:369-382

Published Date: 7 March 2023

Original Research

Efficacy and Safety of Tyrosine Kinase Inhibitors Alone or Combination with Programmed Death-1 Inhibitors in Treating of Hepatitis C-Related Hepatocellular Carcinoma

Lei J, Yang S, Chen B, Zhang L, Yan T, Yang G, Chen Y, Li Y, Lu Y, Zuo S

Journal of Hepatocellular Carcinoma 2023, 10:357-367

Published Date: 2 March 2023

Review

Pathogenesis of NAFLD-Related Hepatocellular Carcinoma: An Up-to-Date Review

Gao Y, Zhu R, Dong J, Li Z

Journal of Hepatocellular Carcinoma 2023, 10:347-356

Published Date: 1 March 2023

Original Research

Exploring Prognosis, Tumor Microenvironment and Tumor Immune Infiltration in Hepatocellular Carcinoma Based on ATF/CREB Transcription Factor Family Gene-Related Model

Shen H, Gu X, Li H, Tang M, Li X, Zhang Y, Su F, Wang Z

Journal of Hepatocellular Carcinoma 2023, 10:327-345

Published Date: 27 February 2023

Original Research

ULK1 Depletion Protects Mice from Diethylnitrosamine-Induced Hepatocarcinogenesis by Promoting Apoptosis and Inhibiting Autophagy

Duan T, Yang X, Kuang J, Sun W, Li J, Ge J, Zhang M, Cai X, Yu P, Yang J, Zhu X

Journal of Hepatocellular Carcinoma 2023, 10:315-325

Published Date: 27 February 2023

Original Research

Efficacy and Safety of Regorafenib Plus Immune Checkpoint Inhibitors with or Without TACE as a Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Yang X, Deng H, Sun Y, Zhang Y, Lu Y, Xu G, Huang X

Journal of Hepatocellular Carcinoma 2023, 10:303-313

Published Date: 27 February 2023

Original Research

PET Imaging of Hepatocellular Carcinoma Using ZD2-(68Ga-NOTA)

Sergeeva O, Zhang Y, Gao S, Chan ER, Sergeev M, Iyer R, Sexton S, Avril N, Lu ZR, Lee Z

Journal of Hepatocellular Carcinoma 2023, 10:291-301

Published Date: 22 February 2023

Original Research

Significance of Physical Status and Liver Function Reserve for Outcome of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib Treatment

Chan KM, Lai Y, Hung HC, Lee JC, Cheng CH, Wang YC, Wu TH, Lee CF, Wu TJ, Chou HS, Wang CT, Chai PM, Lien HY, Lee WC

Journal of Hepatocellular Carcinoma 2023, 10:281-290

Published Date: 18 February 2023

Original Research

Efficacy and Safety of TACE Combined with Regorafenib Plus PD-1 Inhibitor in the Treatment of Hepatocellular Carcinoma After Sorafenib Resistance

Zou X, Xu Q, You R, Yin G

Journal of Hepatocellular Carcinoma 2023, 10:267-279

Published Date: 16 February 2023

Review

Potential Treatment Strategies for Hepatocellular Carcinoma Cell Sensitization to Sorafenib

Jiang Z, Dai C

Journal of Hepatocellular Carcinoma 2023, 10:257-266

Published Date: 15 February 2023

Original Research

Prognosis and Personalized Treatment Prediction in Different Mutation-Signature Hepatocellular Carcinoma

Zhang Y, Liu Z, Li J, Li X, Duo M, Weng S, Lv P, Jiang G, Wang C, Li Y, Liu S, Li Z

Journal of Hepatocellular Carcinoma 2023, 10:241-255

Published Date: 15 February 2023

Original Research

Downstaging and Conversation Strategy for Advanced Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus: TACE, 125I Seed Implantation, and RFA for Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus

Zhao XH, Li HL, Guo CY, Yao QJ, Xia WL, Hu HT

Journal of Hepatocellular Carcinoma 2023, 10:231-240

Published Date: 14 February 2023

Original Research

Novel Nomograms Based on Gamma-Glutamyl Transpeptidase-to-Lymphocyte Ratio Predict Prognosis of Hepatocellular Carcinoma Patients After Hepatectomy

Ma C, Cao Y, Zhang G, Qiu J, Zhou Y, Wang P, Wang S, Yan D, Ma D, Jiang C, Wang Z

Journal of Hepatocellular Carcinoma 2023, 10:217-230

Published Date: 9 February 2023

Original Research

Ozonated Water Inhibits Hepatocellular Carcinoma Invasion and Metastasis by Regulating the HMGB1/NF-κB/STAT3 Signaling Pathway

Tang S, Xu B, Pang H, Xiao L, Mei Q, He X

Journal of Hepatocellular Carcinoma 2023, 10:203-215

Published Date: 10 February 2023

Original Research

Inflammation-Related Marker NrLR Predicts Prognosis in AFP-Negative HCC Patients After Curative Resection

Wu Q, Zeng J, Zeng J

Journal of Hepatocellular Carcinoma 2023, 10:193-202

Published Date: 8 February 2023

Review

Preoperative Immunotherapy in Hepatocellular Carcinoma: Current State of the Art

Laschtowitz A, Roderburg C, Tacke F, Mohr R

Journal of Hepatocellular Carcinoma 2023, 10:181-191

Published Date: 8 February 2023

Original Research

Subcentimeter Nodules with Diagnostic Hallmarks of Hepatocellular Carcinoma: Comparison of Pathological Features and Survival Outcomes with Nodules Measuring 1–2 cm

Huang P, Ni X, Zhou C, Shi Z, Wu F, Xiao Y, Yang C, Zeng M

Journal of Hepatocellular Carcinoma 2023, 10:169-180

Published Date: 8 February 2023

Original Research

Preoperative Evaluation of Hepatocellular Carcinoma Differentiation Using Contrast-Enhanced Ultrasound-Based Deep-Learning Radiomics Model

Qin X, Hu X, Xiao W, Zhu C, Ma Q, Zhang C

Journal of Hepatocellular Carcinoma 2023, 10:157-168

Published Date: 8 February 2023

Original Research

Development and Validation of a Vascular Endothelial Growth Factor A-associated Prognostic Model for Unresectable Hepatocellular Carcinoma

He K, Liu X, Yang Z

Journal of Hepatocellular Carcinoma 2023, 10:139-156

Published Date: 5 February 2023

Original Research

Cisplatin or Doxorubicin Reduces Cell Viability via the PTPIVA3-JAK2-STAT3 Cascade in Hepatocellular Carcinoma

Li CJ, Tsai HW, Chen YL, Wang CI, Lin YH, Chu PM, Chi HC, Huang YC, Chen CY

Journal of Hepatocellular Carcinoma 2023, 10:123-138

Published Date: 30 January 2023

Original Research

Quantitative Assessment of Hypovascular Component in Arterial Phase to Help the Discrimination of Combined Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma

Yang X, Chang J, Li R, Qi Y, Zeng X, Wang W, Li H

Journal of Hepatocellular Carcinoma 2023, 10:113-122

Published Date: 26 January 2023

Original Research

Changes in Presentation, Treatment, and Survival of Patients with Hepatocellular Carcinoma in Damietta, Egypt, 2007–2019: A Retrospective Monocentric Cohort Study

Jean K, Tawheed A, Luong Nguyen LB, Heikal T, Eldaly U, Elhadidy N, Elghaieb A, Aboudonia A, Tondeur L, Dublineau A, Fontanet A, El-Kassas M

Journal of Hepatocellular Carcinoma 2023, 10:99-111

Published Date: 25 January 2023

Original Research

Cd34 Immunostaining Adds Specificity To Microvascular invasion Analysis in Hepatocellular Carcinoma

Gama H, Albuquerque R, Campos Wanderley D, Pascoal Xavier MA, Osório FMF, Couto CA, Ferrari TCA, Lima AS, Diniz PHC, Vidigal PVT

Journal of Hepatocellular Carcinoma 2023, 10:91-98

Published Date: 22 January 2023

Original Research

Efficacy and Safety of Combined Ethanol-Lipiodol Mixture and Drug-Eluting Bead TACE for Large HCC

Chuang YH, Cheng YF, Tsang LLC, Ou HY, Hsu HW, Lim WX, Huang PH, Weng CC, Yu CY

Journal of Hepatocellular Carcinoma 2023, 10:81-90

Published Date: 15 January 2023

Original Research

Evaluation of Lactate Dehydrogenase and Alkaline Phosphatase as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram

Su K, Huang W, Li X, Xu K, Gu T, Liu Y, Song J, Qian K, Xu Y, Zeng H, Yang Y, Guo L, Han Y

Journal of Hepatocellular Carcinoma 2023, 10:69-79

Published Date: 14 January 2023

Original Research

High Platelet Count is a Potential Prognostic Factor of the Early Recurrence of Hepatocellular Carcinoma in the Presence of Circulating Tumor Cells

Lu Z, Huang Y, Huang J, Ni HH, Luo T, Wei X, Bai X, Qi L, Xiang B

Journal of Hepatocellular Carcinoma 2023, 10:57-68

Published Date: 14 January 2023

Original Research

Nomogram Based on Platelet–Albumin–Bilirubin for Predicting Tumor Recurrence After Surgery in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients

Yang C, Wu X, Liu J, Wang H, Jiang Y, Wei Z, Cai Q

Journal of Hepatocellular Carcinoma 2023, 10:43-55

Published Date: 13 January 2023

Original Research

Non-Invasive Imaging Biomarkers to Predict the Hepatopulmonary Shunt Fraction Before Transarterial Radioembolization in Patients with Hepatocellular Carcinoma

Hamm CA, Busch F, Pöhlmann A, Shewarega A, He Y, Schmidt R, Xu H, Wieners G, Gebauer B, Savic LJ

Journal of Hepatocellular Carcinoma 2023, 10:27-42

Published Date: 12 January 2023

Original Research

Yttrium-90 Radioembolization as the Major Treatment of Hepatocellular Carcinoma

Yu CY, Huang PH, Tsang LLC, Hsu HW, Lim WX, Weng CC, Huang TL, Hsu CC, Chen CL, Ou HY, Cheng YF

Journal of Hepatocellular Carcinoma 2023, 10:17-26

Published Date: 11 January 2023

Original Research

Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma

Wang Q, Wang B, Ma X, Zhuang H, Xie Z, Tang C, Tan W, Yang L, Shang C, Chen Y

Journal of Hepatocellular Carcinoma 2023, 10:1-16

Published Date: 10 January 2023